Furthermore, in AD patients it has recently been suggested that decreased ability to identify odors may reflect the burden of tau-mediated neurodegeneration in the mesotemporal lobe (i.e., amygdala, hippocampus and parahippocampal gyrus) [47]. This evidence concerns the gene MAPT and Alzheimer disease.